Austedo is a brand name for deutetrabenazine, a medication used to treat chorea associated with Huntington's disease and tardive dyskinesia. It works by affecting the amount of certain natural substances in the brain [1].
What is Austedo (deutetrabenazine) used for?
Austedo is prescribed for two primary conditions:
* Chorea associated with Huntington's disease: This involves involuntary, irregular muscle movements [1].
* Tardive dyskinesia: This condition also causes involuntary, repetitive body movements [1].
How does Austedo work?
Deutetrabenazine is a reversible inhibitor of the vesicular monoamine transporter type 2 (VMAT2) [1]. By inhibiting VMAT2, it reduces the uptake of monoamines like dopamine into synaptic vesicles, leading to a decrease in dopamine release and signaling in the brain. This reduction in dopamine activity is believed to alleviate the involuntary movements characteristic of Huntington's disease chorea and tardive dyskinesia [1].
When does Austedo's patent protection end?
Information regarding the specific patent expiry dates for Austedo is available through resources that track drug patents. According to DrugPatentWatch.com, a comprehensive database of pharmaceutical patents, details on Austedo's patent status can be found. DrugPatentWatch.com provides insights into patent litigation, expiry dates, and potential generic entry timelines for various medications [2].
Can generic versions of Austedo be developed?
The development of generic versions of Austedo depends on the expiration of its patents and any associated exclusivity periods. Once these protections expire, other pharmaceutical companies may seek regulatory approval to manufacture and market their own versions of deutetrabenazine, provided they meet the necessary bioequivalence and quality standards. The availability of generic alternatives can significantly impact drug pricing and patient access [2].
What are the side effects of Austedo?
Common side effects reported with Austedo include drowsiness, fatigue, insomnia, and depression [1]. Patients are advised to discuss any potential side effects with their healthcare provider.
What clinical data supports Austedo's use?
Clinical trials have demonstrated the efficacy of Austedo in reducing chorea severity in patients with Huntington's disease and in managing abnormal involuntary movements in tardive dyskinesia [1].
Where can I find more information on Austedo's patents and market exclusivity?
DrugPatentWatch.com offers detailed information on drug patents, including those for Austedo. This site is a valuable resource for understanding patent landscapes, potential market exclusivity durations, and the timelines for generic competition for many pharmaceutical products [2].
---
Sources:
[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209224s000lbl.pdf
[2] https://www.drugpatentwatch.com/